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DNA bindingThe interactions of cationic amphipathic antimicrobial peptides (AMPs) with anionic biological membranes
have been the focus of much research aimed at improving the activity of such compounds in the search for
therapeutic leads. However, many of these peptides are thought to have other polyanions, such as DNA or
RNA, as their ultimate target. Here a combination of ﬂuorescence and circular dichroism (CD) spectroscopies
has been used to assess the structural properties of amidated versions of buforin II, pleurocidin and magainin
2 that support their varying abilities to translocate through bacterial membranes and bind to double
stranded DNA. Unlike magainin 2 amide, a prototypical membrane disruptive AMP, buforin II amide adopts a
poorly helical structure in membranes closely mimicking the composition of Gram negative bacteria, such as
Escherichia coli, and binds to a short duplex DNA sequence with high afﬁnity, ultimately forming peptide–
DNA condensates. The binding afﬁnities of the peptides to duplex DNA are shown to be related to the
structural changes that they induce. Furthermore, CD also reveals the conformation of the bound peptide
buforin II amide. In contrast with a synthetic peptide, designed to adopt a perfect amphipathic α-helix,
buforin II amide adopts an extended or polyproline II conformation when bound to DNA. These results show
that an α-helix structure is not required for the DNA binding and condensation activity of buforin II amide.: +44 207 848 4800.
.
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The wide spectrum and rapid bactericidal activity of antimicrobial
peptides has made them the focus of much research, aiming to add to
the current arsenal of antibiotics whose effectiveness is being severely
eroded by the increased prevalence of bacteria resistant to one or
more classical antibiotics [1–4]. Considerable focus has been placed on
themembrane disruptive properties of cationic amphipathic peptides,
although it is recognized that many peptides may have alternative
bactericidal mechanisms requiring them to penetrate bacteria and
interfere with metabolic processes [5,6]. One such peptide, buforin II
derived from the Asian toad Bufo gargarizans, has been shown to
penetrate bacteria, inhibiting cellular functions [7]. Considering the
demonstrated therapeutic efﬁcacy of buforin II in a rat model of
Acinetobacter baumannii sepsis [8], understanding the bactericidal
strategy of buforin II and the underpinning structural contributions
will offer a new avenue in the pursuit of therapeutically relevant
peptide based antibiotics. In comparison with magainin 2, a cationic
amphipathic peptide with well characterized membrane disruptive
properties, buforin II binds DNA and RNA from Escherichia coli with a
much greater afﬁnity [7]. However, the nature of the peptide-nucleicacid interactions and the mechanisms that promote peptide binding
are poorly understood.
To gain an improved understanding of these processes, we
have used a combined circular dichroism (CD) and ﬂuorescence
approach to characterize the binding of buforin II and C-terminal
amidated versions of buforin II, pleurocidin, magainin 2 and two
tryptophan containing analogues (buforin F10W, magainin F5W)
to mixed anionic lipid membranes as well as a short 15 base pair
stretch of duplex DNA which is identical to that used in a recent
molecular dynamics simulation study [9]. Cationic AMPs are often
amidated at the C-terminus to increase activity and in the present
study we have studied amidated versions of buforin II and
magainin 2, comparing like with like, but have also examined
the binding of the non-amidated form of buforin II to assess the
contribution of this modiﬁcation. In contrast with magainin 2
amide and pleurocidin amide, buforin II amide does not adopt
signiﬁcant α-helix conformation in model membranes mimicking
those of Gram negative bacteria. Buforin II amide was observed to
bind to DNA more readily than magainin 2 amide, as expected,
and ψ condensates were indicated by the presence of circular
intensity differential light scattering (CIDS). A sigmoidal response
was observed in thiazole orange ﬂuorescence intercalator dis-
placement (FID) assays for buforin II amide but not for magainin 2
amide unless the phenylalanine at position 5 in magainin 2 amide
was substituted by tryptophan (magainin F5W amide). Finally, the
conformation of buforin II amide bound to DNA was shown to be
1935Y. Lan et al. / Biochimica et Biophysica Acta 1798 (2010) 1934–1943extended (probably PII), not α-helical as suggested by the
molecular dynamics simulation study [9]. The fundamentally
different structural properties of buforin II amide, pleurocidin
amide and magainin 2 amide can therefore be understood to be
crucial in underpinning their distinct antibacterial strategies.
2. Materials and methods
2.1. Peptides, lipids, DNA and E. coli
Peptides (Table 1) were purchased from either EZBiolab (Carmel,
IN) or Pepceuticals Ltd (Nottingham, UK) as desalted grade. Further
HPLC puriﬁcation was performed using methanol/water gradients.
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol
(POPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanol-
amine (POPE), dimyristoyl-sn-glycero-3-phosphatidylcholine
(DMPC) and dimyristoyl-sn-glycero-3-phosphatidylglycerol (DMPG)
were obtained from Avanti Polar Lipids, Inc. (Alabaster, AL) and used
without further puriﬁcation. DNA duplex, as described previously [9],
(AAA TAC ACT TTT GGT and complement, Mw duplex 9141.1,
ε=233,145.9 L mole−1 cm−1) was from Integrated DNA Technolo-
gies (Coralville, IA). E. coli (NCTC 9001) and E. coli TOP10 were gifts
from K.D Bruce (King's College London) and C. Junkes (FMP, Berlin),
respectively. All other reagents were analytical grade or better.
2.2. Liposome preparation
Samples with different lipid compositions were prepared
(molar ratios in brackets): DMPC/DMPG (80:20), POPC/POPG
(80:20) and POPE/POPG (80:20). For the binary lipid mixtures a
total of around 7 mg lipids per sample were dissolved and mixed
in chloroform and dried under rotor-evaporation at room
temperature. In order to remove all organic solvent, the lipid
ﬁlms were exposed to vacuum overnight. The ﬁlms were then
rehydrated with 2 ml of 5 mM Tris-amine buffer at pH 7.0 at room
temperature. Samples were then extruded, passaged eleven times
through a 100-nm ﬁlter at room temperature. Extrusion rendered
the liposomes optically transparent while the liposome sizes,
measured on a Zetaplus (Brookhaven Instruments Corp., Long
Island, NY), were typically in the region of 127 nm (DMPC/DMPG),
100 nm (POPC/POPG) and 128 nm (POPE/POPG) with polydisper-
sity between 0.08 and 0.1.
2.3. Circular dichroism
Spectra were acquired on a Chirascan spectrometer (Applied
Photophysics, Leatherhead, UK). Liposome samples were main-Table 1
Comparison of physical and biological features of peptides used in this study.
Hydrophobicity (H) and mean hydrophobic moment (μH) are shown according to the
Eisenberg scale [44] andwere calculated using the HydroMCalc Java appletmade available
by Alex Tossi (http://www.bbcm.univ.trieste.it/~tossi/HydroCalc/HydroMCalc.html).
* Mean hydrophobic moment assuming formation of ideal α-helix.
Peptide Sequence Charge (H) (μH)⁎
Buforin II amide TRSSRAGLQFPVGRVHRLLRK-NH2 +7 −0.37 0.3
Buforin F10W
amide
TRSSRAGLQWPVGRVHRLLRK-NH2 +7 −0.38 0.3
Buforin II TRSSRAGLQFPVGRVHRLLRK +6 −0.37 0.3
Magainin 2 amide GIGKFLHSAKKFGKAFVGEIMNS-NH2 +4 −0.03 0.28
Magainin F5W
amide
GIGKWLHSAKKFGKAFVGEIMNS-
NH2
+4 −0.04 0.27
Pleurocidin amide GWGSFFKKAAHVGKHVGKAALTHYL-
NH2
+5 −0.02 0.22
LAK KKLAKALKLLALLWLKLAKALKKA-
NH2
+9 −0.09 0.34tained at 37 °C while DNA binding experiments were performed at
room temperature. For liposome experiments, spectra were
recorded from 260 to 185 nm for liposomes composed of lipids
with saturated acyl chains or from 260 to 195 nm when mono-
unsaturated acyl chains were present. Lipid suspension was added
to a 0.5-mm cuvette at a ﬁnal concentration of 4.8 mM and then a
few μl of a concentrated peptide solution were added and
thoroughly mixed to give a ﬁnal peptide concentration of 24 μM
and a peptide-to-lipid molar ratio of 1:200. In processing, a
spectrum of the peptide free suspension or solution was
subtracted and Savitsky–Golay smoothing with a convolution
width of 5 points applied. Secondary structure analyses were
performed using CDPro [10]. For DNA measurements both near
and far-UV CD spectra were obtained. Near-UV measurements
were performed in a 10 mm cell, recording from 340 to 220 nm;
far-UV measurements were performed on the same sample in
1 mm cells recording from 260 to 185 nm. DNA was prepared at a
concentration of 1.66 μM and was titrated through the addition of
small volumes (1–2 μl) of 5 mg/ml peptide stock solutions. UV
absorbance spectra, acquired simultaneously with the CD mea-
surements, are presented without correction in the supplementary
materials to show the effects of light scattering and here, after
being zeroed at 340 nm, to allow the absorbance at 260 nm to be
followed more readily. The CD intensities at 272 nm were plotted
as a function of the change in peptide to DNA molar ratios. The
slope quoted for each peptide (Table 3) is the average of two
independently repeated experiments.
2.4. Thiazole orange ﬂuorescence intercalator displacement (FID)
Emission spectra of thiazole orange loaded onto the 15 base
pair DNA duplex were acquired using a Cary Eclipse ﬂuorimeter
using an excitation wavelength of 519 nm and scanning from
520 nm to 600 nm. 1 ml of a 0.41 μM DNA solution loaded with
thiazole orange in a 4 mm×10 mm cuvette was titrated with small
volumes of peptide. Normalized ﬂuorescence intensity at 527 nm
was plotted against the change in peptide/DNA molar ratio and
ﬁtted using the nonlinear curve ﬁtting regime in Origin 8 (Origi-
nLab Corporation, Northampton, MA) in order to extract an EC50,
deﬁned as the peptide to DNA molar ratio that is required for half
the available binding sites on the DNA to be occupied. The EC50 is
used here as a qualitative comparison of the binding afﬁnities of
the peptides to the duplex DNA. While the binding response
curves mostly displayed a strong sigmoidal character, the response
of magainin 2 amide only could be described in terms of a single
exponential. Binding characteristics extracted in this way are
quoted (Table 3) as the average of two independent repeats of the
assay.
2.5. Broth micro-dilution assay
The activities of the peptides against two strains of E. coli were
assessed in planktonic suspension in polypropylene 96 well plates
(Greiner Bio-one, Frickhausen, Germany) according to a modiﬁed
broth dilution assay [11]. E. coli (NCTC 9001), competent E. coli
TOP10 or Pseudomonas aeruginosa (PAO1) were grown without
shaking in 50 ml Mueller-Hinton (MH) broth at 37 °C. Peptides
were tested in duplicates with two rows allocated for each
peptide. In each of columns 2–11, 50 μl of MH broth was added
under sterile conditions. In the ﬁrst row, 50 μl of 256 μg/ml stock
peptide solutions prepared in distilled water were added and then
the broth from the second row was pipette into the ﬁrst row and
thoroughly mixed before being deposited again in the second row.
This process was repeated throughout the tray providing a twofold
dilution of peptide with each row. Bacteria with an OD620 of
0.0001 were then added in volumes of 50 μl giving a further
1936 Y. Lan et al. / Biochimica et Biophysica Acta 1798 (2010) 1934–1943twofold dilution and a ﬁnal volume of 100 μl per well. The ﬁnal
column was used either as sterility control (100 μl broth) or
negative control (no peptide). Plates were incubated overnight at
37 °C and the OD620 read. Growth curves prepared from duplicates
were ﬁtted to determine the peptide concentration required to
inhibit growth by 50% (MIC50). The MIC50 quoted for each peptide
(Table 1) is an average value from four independent repeats.Fig. 1. Circular dichroism spectra of buforin II amide (A/E), magainin 2 amide (B/F) or pleur
presence of various mixed anionic/zwitterionic lipid vesicles (D–F) where the anionic compo
The temperature was 37 °C and the ﬁnal peptide concentration was 24 μM.3. Results
3.1. Circular dichroism—membrane binding
Circular dichroism (CD) measurements of the peptides in the
presence of membrane mimetic media and lipid vesicles of differing
composition provide information on the average secondary structureocidin amide (C/D) in solution (5 mM Tris pH 7, 50% TFE or 50 mM SDS) (A–C) or in the
nent comprised 20% of the lipid by mole and the peptide to lipid molar ratio was 1:200.
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amide, magainin 2 amide and pleurocidin amide are all cationic
peptides but each has a number of uncharged polar or hydrophobic
residues. At lower concentrations, magainin 2 is known to adopt an
amphipathic α-helical conformation in membranes with the helix
long axis aligned parallel to the membrane surface [12–16]. This
enables charged residues to interact with the polar or charged lipid
headgroups while hydrophobic residues are oriented towards the
hydrophobic core of the membrane. CD measurements of magainin 2
amide (Fig. 1B) and its tryptophan analogue (Supp. Fig. 1B) conﬁrm
that in aqueous solution both peptides adopt a disordered structure.
As expected, in the presence of 50% TFE, which excludes water to
promote intra-molecular hydrogen bonding, CD spectra are obtained
that are consistent with a considerable ordered α-helical content.
CD spectra indicating an even greater α-helical content are
obtained in the presence of micelles formed by the anionic
detergent SDS. Analyses of the spectra using CDPro provides a
numerical estimate of the helical content (Table 2). Hence, in both
membrane mimicking media, magainin 2 amide adopts a confor-
mation with a substantial α-helical content. Pleurocidin amide
behaves similarly to magainin 2 amide, both in aqueous solution
and in membrane mimicking media (Fig. 1C). Buforin II amide has a
greater overall charge and lower hydrophobicity than magainin 2
amide, but formation of an α-helix would lead to a separation of
charged and hydrophobic residues giving a comparable hydropho-
bic moment (Table 1). The structure of buforin II has been
determined previously using solution state NMR methodologies in
50% TFE [17]. The obtained conformation indicates a regular α-helix
only between Val12 and Arg20 and, after the proline induced kink, a
helical section with a pitch of −6.82 Å. This alternate helical
arrangement ensures the amphipathic region extends from Arg5
right through to Lys21 [17]. In the present study, the CD spectra of
buforin II amide (Fig. 1A) and its tryptophan mutant (Supp. Fig. 1A)
are indistinguishable from each other in aqueous or membrane
mimicking environments (Table 2). CD indicates that both buforin II
amide peptides adopt a disordered structure in aqueous solution. In
50% TFE, but not in the presence of SDS micelles, both buforin II
amide peptides become more ordered. This behavior is distinctly
different from both magainin 2 amide and pleurocidin amide. The
sensitivity of the Chirascan spectrometer allows spectra with good
signal-to-noise enabling measurements with peptide-to-lipid molar
ratios as low as 1:200. At this ratio, sufﬁcient negative charge is
maintained, for liposomes with approximately 20 mol percent
anionic lipid, after peptide binding that liposome aggregation and
concomitant light scattering do not impair the measurements.
Spectra obtained in this way are shown for a variety of liposome
compositions (Fig. 1D–F); spectra obtained at the higher peptide-
to-lipid molar ratio of 1:100 were similar (not shown) but at higher
peptide-to-lipid molar ratios (circa 1:50), considerable light
scattering was observed, compromising spectra particularly at
shorter wavelengths. Three binary lipid mixtures were used withTable 2
Comparison of α-helix content derived from CDPro analysis of the spectra in Fig. 2.
Spectra were analyzed between 260 and 185 nm in solution, 50% TFE and 50 mM SDS
and between 260 and 195 nm for lipid suspensions.
Peptide α-Helix content
5 mM
Tris
50%
TFE
50 mM
SDS
DMPC/
DMPG
POPC/
POPG
POPE/
POPG
Buforin II amide 0.04 0.28 0.13 0.26 0.33 0.36
Buforin F10W amide 0.06 0.35 0.10 0.20 0.28 0.25
Buforin II amide 0.05 0.20 0.23 0.16 0.19 0.19
Magainin 2 amide 0.05 0.50 0.76 0.91 0.90 0.90
Magainin F5W amide 0.06 0.48 0.81 0.93 0.89 0.91
Pleurocidin amide 0.05 0.47 0.83 0.89 0.84 0.47either DMPG or POPG as the anionic component and either POPC or
POPE as the zwitterionic component. Membrane lipid charge ratios
were chosen to match those of the inner membrane of E. coli with
POPE/POPG (80:20) being the closest match. POPC/POPG or
DMPG/DMPG allowed an assessment of the effect of changing the
zwitterionic lipid headgroup or replacing mono-unsaturated acyl
chains with saturated chains, respectively. At 37 °C, corresponding
to physiological temperature for a bacterium within a human host,
the CD spectra obtained for magainin 2 amide (Fig. 1F) and the F5W
analogue (Supp. Fig. 1D) in these mixed lipid membranes and the
CDPro analyses indicate that both peptides adopt an almost
identical α-helix conformation to a much greater extent than in
SDS micelles or 50% TFE. In this case, the SDS micelle is a better
mimic for the liposome vesicle environment than 50% TFE. In
contrast, buforin II amide (Fig. 1E) and the F10W analogue (Supp.
Fig. 1C) show a greatly reduced tendency to becoming ordered in
all the liposome environments; the very modest tendency to adopt
any α-helical conformation correlates more with 50% TFE than SDS
micelles. The α-helical content of buforin II, with a free C-terminus,
was even lower than that of the amidated analogue in 50% TFE and
all three lipid environments (Table 2). CD spectra obtained for
pleurocidin amide in the same liposome environments (Fig. 1D)
indicated that the peptide adopted an α-helix conformation, similar
to that of the two magainin 2 amide peptides except when added to
POPE/POPG membranes where a substantial reduction in α-helix
conformation is observed when compared with magainin 2 amide
in POPE/POPG and its own conformation in either POPC/POPG or
DMPC/DMPG.
3.2. Thiazole orange ﬂuorescence intercalating displacement assay
A thiazole orange ﬂuorescent intercalating displacement (FID)
assay [18] has been employed to determine the binding character-
istics of the buforin and magainin peptides to a short DNA duplex.
The reduction in ﬂuorescence intensity from the DNA bound dye,
following addition of increasing amounts of each peptide, is taken
to be a measure of the fraction of peptide displacing the dye and
binding to the DNA. The increase in the bound fraction of peptide is
shown as a function of the peptide to DNA molar ratio (Fig. 2A). For
all of the peptides, except magainin 2 amide, the decay of the
ﬂuorescence intensity has a clearly sigmoid form. Extracting values
for the peptide/DNA molar ratio required for half of the dye to be
displaced (EC50) allows a comparison of the binding characteristics
of each of the peptides (Table 3). Cationic AMPs are often amidated
at the C-terminus to increase activity and in the present study we
have studied amidated versions of buforin II and magainin 2,
comparing like with like, but have also examined the binding of the
non-amidated form of buforin II to assess the contribution of this
modiﬁcation. Buforin II amide and buforin F10W amide had the
greatest afﬁnity for the duplex DNA. The EC50 for these two
peptides was nearly fourfold lower than that of magainin 2 amide,
the difference also being signiﬁcant (pb0.05). Buforin II, where the
C-terminal is not amidated, had a binding afﬁnity that was
signiﬁcantly greater than that of both magainin peptides (pb0.05)
and not signiﬁcantly weaker than that of the two amidated buforin
peptides. Magainin 2 amide had the weakest binding afﬁnity and
was the only one of the peptides whose binding could be
satisfactorily ﬁtted with a single exponential. Mutation of Phe5 to
tryptophan caused an almost twofold increase in the afﬁnity of
magainin 2 to the duplex DNA which is also signiﬁcant (pb0.05)
and introduced a sigmoidal response to the binding and displace-
ment mechanism. In contrast, the binding afﬁnity of buforin II
amide and buforin F10W amide were indistinguishable (Fig. 2B).
Pleurocidin amide has intermediate DNA binding capabilities with
an EC50 that was greater than that of the three buforin peptides but
lower than those of the two magainin peptides.
Fig. 2. Thiazole orange ﬂuorescent indicator displacement assays performed at room temperature for buforin II amide, magainin 2 amide and their tryptophan containing mutants
with the 15 base pair duplex DNA (A). The same data are shown on an expanded scale for buforin II amide and buforin F10W amide (B). The DNA concentration was 0.41 μM.
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Near-UV circular dichroismspectra of the duplexDNA in solution are
characteristic of those obtained for the B form of DNA (Fig. 3A, C, E). A
strong positive signal is observed between 260 and 290 nmwith, in this
case, a shoulder observable around 272 nm. Similarly, a strong negative
signal is observed between 230 and 260 nm. Near-UV spectra are
suitable for monitoring the response of DNA to the addition of peptide.
CD contributions above 250 nm due to peptide are negligible, despite
the presence of phenylalanine and tryptophan residues in the peptide
sequences (Supp. Fig. 4). Addition of small amounts of buforin II amide
causes dramatic changes in both the CD spectra (Fig. 3A) and
simultaneously obtained absorbance spectra (Fig. 3B). Initially the
shoulder observed in the CD at 272 nm is seen to fall while the signal
between 230 and 260 nm as well as the characteristic DNA absorbance
at 260 nm remain unaffected. When between three and four molar
equivalents of buforin II amide have been added to the complex, the
absorbance at 260 nm begins to collapse with the onset of turbidity
(Fig. 3B); circular intensity differential light scattering now dominates
the CD spectrum as the DNA becomes condensed by the peptide. At this
stage the CD spectra take on a greatly altered form as a positive intensity
builds around 290 nm, the shoulder at 272 nm is completely absent and
substantial rearrangements occur in the region between 230 and
260 nm. In contrast, the effects of magainin 2 amide on the same DNA
duplex are much more moderate (Fig. 3C) with those of pleurocidin
amide being intermediate between buforin II amide and magainin 2
amide (Fig. 3E). The CD shoulder at 272 nm, for DNA challenged with
magainin 2 amide, ismuchmore resistant to the addition of peptide and
remains almost throughout the course of the experiment. The
corresponding absorbance spectra show substantial hypochromism;
the absence of turbidity (light scattering) above 310 nm indicates that
the DNA remains in solution (Fig. 3D). The change in intensity of the CDTable 3
Comparison of the DNA binding characteristics and antimicrobial activities of the cationic p
Peptide EC50 ΔCD @ 272 nm
Buforin II amide 2.51±0.64 −0.198±0.007
Buforin F10W amide 2.52±0.49 −0.220±0.016
Buforin II 3.78±0.29 −0.133±0.029
Magainin 2 amide 9.45±0.71 −0.066±0.024
Magainin F5W amide 5.29±0.50 −0.113±0.020
Pleurocidin amide 4.32±0.80 −0.121±0.003(272 nm) is the most notable event in the initial stages of the peptide/
DNAbinding process and hence this is plotted as a function of peptide to
DNAmolar ratio (Fig. 4A) for as longas theDNA remains in solution. This
allows the rate of change of this feature to be used as a means of
providing a quantitative comparison of peptides with a putative DNA
binding bactericidal strategy. A peptide concentration dependent
reduction of the CD (272 nm) intensity is observed upon addition of
peptide. Extracting a slope from these plots enables the structural
rearrangements observed by CD to be related to the binding afﬁnities
and modes of the peptides (Table 3). This relationship between the
binding afﬁnity of the peptides and the structural changes ismademore
apparent by plotting the change in CD (272 nm) signal for each peptide
as a function of the corresponding measured relative dissociation
constant (Fig. 4B). This plot reveals the trendwhereby the peptideswith
the greatest afﬁnity for theDNAduplex also cause the greatest change in
the CD (272 nm) signal. The two amidated buforin peptides have both
the highest afﬁnity for the DNA duplex and induce the greatest changes
in CD, greater than those induced by either magainin peptide (pb0.05).
Magainin 2 amidehas the lowest afﬁnity and induces the least change in
CD. The observed increase in the effect of this peptide on the CD
(272 nm) signal following replacement of Phe5 with tryptophan
however may or may not be signiﬁcant (p=0.165). Equally, buforin II,
with a free C-terminal, has both a slightly reduced afﬁnity for the DNA
duplex and also causes slightly less of an effect on the CD (272 nm)
signal when comparedwith the amidated analoguewhich againmay or
may not be signiﬁcant (p=0.09). Pleurocidin amide has intermediate
binding afﬁnity (Table 3) and is observed to also have an intermediate
effect on the CD (272 nm) signal.
Finally, far-UV spectra were obtained to observe CD attributable to
the peptide (Fig. 5A–D). In this region, the optical pathlength was
0.5 mm, twenty fold less than the 1 cmused in the near UV. Nucleic acid
contributions are now less signiﬁcant. In contrast with the structureeptides. Dissociation constant (EC50) derived from thiazole orange FID assay.
MIC50
E. coli (NCTC 9001) E. coli (TOP10) P. aeruginosa (PAO1)
N26.30 N26.30 N26.30
N25.89 N25.89 N25.89
N26.28 N26.28 N26.28
6.86±1.58 1.79±0.13 10.60±2.21
4.21±1.29 1.25±0.28 7.29±2.73
0.66±0.22 0.18±0.02 1.65±0.87
Fig. 3. Typical circular dichroism (A, C) and zeroed UV (B, D) spectra of 15 base pair duplex DNA incubated with increasing amounts of either buforin II amide (A, B) or magainin 2
amide (C, D) at room temperature. The DNA concentration was typically between 1 and 2 μM. The peptide to DNA molar ratios are given.
1939Y. Lan et al. / Biochimica et Biophysica Acta 1798 (2010) 1934–1943determined by NMR and with the far-UV spectra described above for
buforin II inmembrane ormembranemimicking environments, little or
no evidence of an α-helical conformation is observed for buforin II
amide bound to duplexDNA (Fig. 5A). Instead, in the spectra acquired at
[peptide]/[DNA] ratios below 4, the strong negative CD signal at around
195 nm coupled with the absence of a negative band between 220 and
230 nm suggests the peptide adopts an extended conformation. Further
work is required to distinguish between a disordered or polyproline IIconformation. At peptide to DNA molar ratios below 4, the negative
band has a negative maximum at 195 nm which shifts toward 199 nm
asmore peptide is added (Fig. 5A). These spectra, recorded at peptide to
DNA molar ratios greater than 4, have greater contributions from
peptides either in solution or not directly bound to DNA. Notably, a
negative maximum of 199 nm is observed for buforin II amide in
solution (Fig. 1A). This suggests a possible polyproline II conformation
[19] for those peptide molecules directly bound to the DNA duplex.
Fig. 4. The change in normalized CD as a function of peptide to duplex DNA molar ratio reveals the differential effect of ﬁve peptides on molecular CD events (A). The change in
normalized CD at 272 nm (as shown in panel A) is plotted as a function of the relative dissociation constant (EC50) for each peptide revealing the relationship between the two
parameters (B).
Fig. 5. Comparison of far-UV circular dichroism spectra for buforin II amide (A), pleurocidin amide (B), magainin 2 amide (C) and LAK (D) reveals the conformation of the peptide
bound to the DNA duplex. Spectra obtained at peptide to DNAmolar ratios between 0 and 4, with darker traces, likely correspond to peptide directly bound to DNA. Lighter traces, for
spectra at higher peptide to DNA molar ratios, will have contributions from non-annular bound peptides or peptides remaining in solution.
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withoutobservationof anexpected,weak, positivebandaround215 nm
whichwould be obscured in the present experiment by signals from the
DNAduplex.Nevertheless, theexperimental evidence strongly indicates
that buforin II amide does not bind to duplex DNA in an α-helix
conformation. Similar experiments were performed for pleurocidin
amide (Fig. 5B) and magainin 2 amide (Fig. 5C). Again focusing on
spectra recorded at peptide:DNA ratios b4, no evidence of an α-helix
conformation is observed. For comparison, a similar experiment was
performed with a designed cationic peptide, LAK (Fig. 5D), which has a
comparable effect to that of buforin II amide, on the near-UV spectra of
the duplex DNA (Supp. Fig. 3). At peptide-to-DNA ratios below 4, this
peptide adopts an α-helical structure when bound in a peptide-DNA
complex, according to the strong negative bands at 205 and 220 nmand
strong positive band at 195 nm observed in the corresponding far-UV
spectra (Fig. 5D). The LAKpeptide is designed to adopt an almost perfect
amphipathic α-helix in media that support such conformations and is
used here to highlight the ability of the far-UV CD spectra to identify an
α-helix conformation in peptides bound to the DNA duplex. In contrast,
such α-helix conformation is clearly absent from buforin II amide,
magainin 2 amide or pleurocidin amide when bound to DNA.
3.4. Broth micro-dilution assay
The antibiotic activity of the peptides was tested against two
separate strains of E. coli and one of P. aeruginosa. NCTC 9001 is a type
strain while TOP10 is a competent strain with a genotype similar to
that of DH10B which is deﬁcient in galU, galK and galE [20].
Inactivation of galE perturbs the incorporation of glucose into the O-
side chain of lipopolysaccharide (LPS) and hence E. coli TOP10 are
expected to have an altered LPS structure. E. coli TOP10 were more
susceptible to AMP challenge than the type strain while the amidated
magainin peptides were substantially more effective than the
corresponding amidated buforin peptides against both strains
(Table 3). The buforin peptides had only a modest affect on bacterial
growth at the highest peptide concentration tested, insufﬁcient for
the determination of an MIC, and no differences in activity were
observed between buforin II with either free or amidated C-termini or
between buforin II amide and buforin F10W amide. Buforin peptides
have previously been reported to have anti-bacterial activities that far
surpass those of magainin 2 [21]. The previous report used an agar
diffusion protocol where the bacterial cells were washed in cold
10 mM sodium phosphate buffer prior to challenge. Our procedure
involves challenge of planktonic cultures of bacteria, according to
commonly used procedures [11], and is consistent with the
observation that phosphatidylethanolamine lipids, abundant in the
membranes of Gram-negative organisms, abolish the membrane
translocation of buforin II necessary for its supposed intracellular
targeting antibacterial strategy [22]. Interestingly, a small but
signiﬁcant enhancement of activity was observed for magainin F5W
amide over magainin 2 amide against both strains of E. coli (pb0.05)
and may apply also against P. aeruginosa (p=0.07).
4. Discussion
Cationic AMPs are diverse in structure and mechanisms of action
[5,6] and therefore present an interesting challenge to those using a
rational design strategy to develop them as anti-infective therapeutic
compounds [1–4]. While it is recognized that AMPs with unrelated
structural properties may operate with distinct mechanisms [5,6] it
has also been suggested that it is sufﬁcient for a peptide to satisfy a set
of physico-chemical conditions for broad spectrum antibacterial
activity to be conferred [23]. The argument follows that secondary
structure is unimportant for the activity of AMPs and that directed
combinatorial methods will be the most fruitful path to incremental
increases in the potency of AMPs. However, data from the same studyindicates that disrupting secondary structure in AMPs dramatically
reduces activity against Gram negative bacteria [23], indicating that
secondary structure is important for activity against organisms such
as E. coli and P. aeruginosa but not Gram positive bacteria. The
composition of bacterial membranes varies considerably from species
to species and has been shown to be an important predictor of
antimicrobial potency [24]. Furthermore, biophysical evidence is
emerging that shows that the pore forming behavior of an individual
peptide will vary considerably according to the membrane composi-
tion [25,26]. Taken together, these reports suggest that understanding
the structural contributions to species speciﬁc mechanisms of action
will enable the design of peptides that can target bacteriawith deﬁned
characteristics.
Pexiganan, or MSI-78, is a highly potent AMP derived from
magainin 2, a naturally occurring peptide identiﬁed in the skin of the
African frog Xenopus laevis. Pexiganan is the best studied AMP for
therapeutic purposes to date and it, like magainin 2, is an amphipathic
α-helical peptide proposed to operate via the formation of toroidal
pores in bacterial membranes [27,28]. Measurements employing a
variety of biophysical methods indicate that magainin 2 binds to
membranes in an orientation with the long axis of the helix parallel to
the membrane surface [13–16] but then, as its concentration in the
membrane increases above a certain threshold, neutron in-plane
scattering studies suggest a trans-membrane alignment is adopted
which enables the peptides to line a toroidal shaped pore [28,29].
Interestingly however, both molecular dynamics simulations and
experimental studies have shown that related cationic amphipathic
α-helical peptides, including magainin H2 and pleurocidin amide, are
capable of forming pores at concentrations where a surface alignment
for the peptide is maintained [30–32]. The molecular dynamics study
further revealed that, under these conditions, magainin H2 was
capable of translocating from the external to the internal leaﬂet of the
membrane [30], as has been observed experimentally for magainin 2
[24]. Furthermore, the potent antibacterial activity of designed
amphipathic α-helical peptides has been shown, in a recent study
[33], to be unrelated to their ability to form pores. Suspecting an intra-
cellular targeting strategy for these peptides, we are interested in
understanding the structural properties that underpin this alternative
mechanism of antibacterial action.
Buforin II is a potent AMPwhich has been shown to kill bacteria by
penetrating the cell membrane and inhibiting cellular functions
[7,34]. Buforin II translocates across model membranes causing
minimal disruption to the membrane [35] but, as the translocation
of both buforin II and magainin 2 are inhibited by negative-curvature
inducing lipids including phosphatidylethanolamine (PE), there have
been proposed to be both similarities [22] and strong differences [35]
between the translocation mechanisms of these peptides. The role of
Pro11 in the translocation of buforin II is crucial as mutation of this
residue abrogates the ability of the peptide both to translocate across
modelmembranes without disrupting themembrane and penetrate E.
coli cells [35,36]. In the NMR structure, determined in a mixture of
H2O and TFE, the Pro11 residue distorts the helix affecting the
positioning of hydrophobic and charged residues [17]. Previous CD
measurements indicate that this structure is maintained in anionic
lipid membranes [35] while the present study conﬁrms this structure
is also maintained in mixed anionic/zwitterionic membranes
designed to mimic those of Gram negative bacteria. This result
contradicts a recently reported combined molecular dynamics (MD)
and CD based analysis [37]. The MD study showed an increased
proportion of α-helix in the N-terminal region of buforin II in the
presence of PE lipids and interpreted CD with mixed POPE/POPG
vesicles as having a greater α-helical character. However, the
molecular dynamics study did not adequately reproduce existing
experimental data. In the MD simulations, the α-helical conformation
of the peptide was maintained in an aqueous environment while the
peptide also bound to neutral lipid membranes. Both these results
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dered structure in aqueous solution and does not bind to vesicles
comprising zwitterionic lipids only [35]. The CD spectra obtained in
support of these simulations were obtained at 25 °C, the phase
transition temperature of POPE, and at peptide-to-lipid ratios where
we have seen considerable impairment of the spectra from light
scattering due to charge neutralization of the anionic liposomes by
cationic peptide. Such light scattering is evident in the reported
spectra [35]. According to its supposed mode of action, buforin II is
proposed to readily translocate across bacterial membranes. Lipids,
such as egg yolk L-α-phosphatidylethanolamine (EYPE), which
induce negative membrane curvature, abolish such translocation
however [34]. The membrane order in the POPE/POPG and DMPC/
DMPG systems will be considerably greater than that of the POPC/
POPG [38,39], as a result of the small ethanolamine headgroup size
and saturated chains respectively. These differing membrane envir-
onments might be expected to exert considerable inﬂuence on the
secondary structure of membrane inserted peptides. However, since
the present study indicates both buforin II and buforin II amide adopt
a very similar conformation in each of the three mixed zwitterionic/
anionic membranes and that the nature of the zwitterionic lipid has
little or no effect on the structure adopted by the peptide, a
conformational change in buforin II is therefore not implicated in
the mechanism by which PE lipids inhibit its translocation. In model
membranes, the α-helical content of buforin II with a free C-terminus
was lower still than the two amidated analogues, supporting a role for
C-terminal amidation in aiding membrane insertion, as observed for
other cationic α-helical AMPs [40].
Mutations in the buforin sequence have been shown experimen-
tally to reduce binding of peptide to a DNA duplex and impair the
antibacterial activity of the peptide [9]. Seeking to understand the
structural properties of buforin that underpin its ability to bind DNA,
we devised a combined FID and CD approach to monitor the binding
and structural responses of both peptides and DNA when a series of
antibacterial peptides bind to a DNA duplex, identical in sequence to
that in the previous study [9]. Both the FID assay and CD study of
peptide binding to duplex DNA in the present work conﬁrm previous
reports that buforin II has a high afﬁnity for nucleic acids [7].
Interestingly, we have shown that the binding afﬁnity of each peptide
is reﬂected in the conformational changes observed in the
corresponding near-UV CD spectra. The method is also sufﬁciently
sensitive to detect that mutation of Phe5 to tryptophan in magainin 2
amide increased the binding afﬁnity for DNA and affected the
apparent mode of binding which may be related to a modest
enhancement in the antibacterial activity. The sigmoidal response of
the FID assay might be taken to suggest cooperativity in the mode
binding of the peptides to duplex DNA, with the exception of
magainin 2 amide. However, this may not accurately reﬂect the
situation within bacteria nor, indeed, in the near-UV CD experiments.
The binding parameters obtained from the FID assay are inﬂuenced
not only by the binding of peptide to DNA but by the competitive
binding of the dye. With two competing binding processes, the data
from the FID assay may either exaggerate cooperativity or suggest
cooperativity that would otherwise not be present were it not for the
presence of dye and hence, at present, we restrict our analysis to a
qualitative comparison of the dissociation constants determined for
each peptide.
Binding of buforin II amide to duplex DNA induced strong changes
in the CD spectra attributable to the DNA duplex. The origin of the
observed changes in the CD spectra is presently unknown but may
occur as a result of changes in base-pair stacking and/or geometry of
the double helix as CD spectra of nucleic acids are known to be
sensitive to these parameters [41]. Hypochromism observed in the
DNA UV absorption at 260 nm is strong evidence that the duplex
conformation remains with stronger base-base interactions. For each
of the peptides included in the present study, the UV/CD spectraassociated with the peptide/DNA titration indicating a two-step
process needs to be considered. The ﬁrst step, up to peptide-to-DNA
mole ratios of 3.5, involves simply the binding of the peptide; above a
mole ratio greater than 3.5, charge neutralization with the formation
of peptide–DNA–ψ-condensates dominates. Concentration dependent
changes in molecular CD, with no sigmoidal character, were
observable as up to four molar equivalents of peptide were added to
the DNA duplex. This amount of peptide was sufﬁcient to displace
more than 90% of the dye in the corresponding FID assay. Addingmore
than four molar equivalents of buforin II amide to the DNA duplex
leads to the formation of a DNA condensate with the spectra then
dominated by circular intensity differential light scattering. The
spectra obtained for buforin II amide DNA condensates are similar
in appearance to those observed for positive ψ condensates formed by
incubating DNA with poly(lysine-alanine) and are indicative of the
formation of structures with long range order [42]. Interestingly
buforin II amide, bound to the DNA duplex in the concentration range
inducing the initial changes in near-UV CD, is shown to adopt an
extended conformation rather than the helical conformation adopted
in membranes or proposed from an MD simulation study [9]. Again
the experimental data does not support the existing view provided by
simulations and further work is required to develop a combined
experimental/simulation approach in order to understand how the
extended buforin II peptides condense duplex DNA.
The ability of a third antibacterial peptide, pleurocidin amide, to
complex and condense DNAwas also assessed. Pleurocidin amide had
a reduced ability to bind DNA when compared with buforin II amide
but had stronger interactions with the duplex than either of the two
magainin peptides. Of the peptides tested in the present study,
pleurocidin amide had by far the greatest activity against the Gram-
negative organisms E. coli and P. aeruginosa. However, as pleurocidin
amide demonstrated only intermediate DNA binding activity, this
property cannot completely account for the high antibacterial potency
of the peptide. Nevertheless, the DNA binding properties of
pleurocidin amide may make some contribution to its potency and
are consistent with previous reports of pleurocidin and its derivatives,
including pleurocidin amide, entering E. coli and inhibiting macro-
molecular synthesis [43]. As noted above, pleurocidin amide interacts
with mixed zwitterionic/anionic membranes in a similar fashion to
magainin peptides, adopting a surface alignment and speciﬁcally
disordering the acyl chains of anionic lipids in such membranes [30].
In the present study, Chirascan CD measurements have allowed a
more sophisticated investigation of the conformations adopted by
pleurocidin amide. Interestingly, though pleurocidin amide adopts a
very similar α-helix conformation to magainin 2 amide in solution
and most membrane mimicking environments, in phosphatidyleth-
anolamine richmembranes a conformation with a lower content ofα-
helix is preferred. The link between this membrane conformation,
observed for pleurocidin amide in membranes mimicking those of
Gram-negative bacteria, and its translocation abilities would throw
light on the mechanism underpinning the translocation of antimicro-
bial peptides into their bacterial targets.5. Conclusion
The present study demonstrates that the conformation adopted by
buforin II amide when binding to, and condensing, duplex DNA differs
from that adopted in membranes. The conformation of buforin II
amide in membranes is not dominantly α-helix and the peptide has
poor membrane translocation ability compared with magainin 2
amide, which is strongly α-helical and capable of translocating
membranes composed of lipids found in the membranes of Gram-
negative bacteria. Since α-helix conformation appears important for
membrane translocation but not for DNA binding and condensation,
potent antibacterial peptides can be considered in the future that are
1943Y. Lan et al. / Biochimica et Biophysica Acta 1798 (2010) 1934–1943capable of adopting structures that promote membrane translocation,
DNA binding and DNA condensation.
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